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SHORT ABSTRACT:  
This article describes a simple and rapid protocol to evaluate the oligomeric state of the 
dynamin-like GTPase MxA protein from lysates of human cells using a combination of non-
denaturing PAGE with western blot analysis. 
 
LONG ABSTRACT:  
The formation of oligomeric complexes is a crucial prerequisite for the proper structure and 
function of many proteins. The interferon-induced antiviral effector protein MxA exerts a broad 
antiviral activity against many viruses. MxA is a dynamin-like GTPase and has the capacity to 
form oligomeric structures of higher order. However, whether oligomerization of MxA is 
required for its antiviral activity is an issue of debate. We describe here a simple protocol to 
assess the oligomeric state of endogenously or ectopically expressed MxA in the cytoplasmic 
fraction of human cell lines by non-denaturing polyacrylamide gel electrophoresis (PAGE) in 
combination with Western blot analysis. A critical step of the protocol is the choice of 
detergents to prevent aggregation and/or precipitation of proteins particularly associated with 
cellular membranes such as MxA, without interfering with its enzymatic activity. Another crucial 
aspect of the protocol is the irreversible protection of the free thiol groups of cysteine residues 
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by iodoacetamide to prevent artificial interactions of the protein. This protocol is suitable for a 
simple assessment of the oligomeric state of MxA and furthermore allows a direct correlation 
of the antiviral activity of MxA interface mutants with their respective oligomeric states. 
 
INTRODUCTION:  
The quaternary structure of a protein plays a crucial role in many cellular processes. Signaling 
pathways, gene expression, and enzyme activation/deactivation all rely on the proper assembly 
of protein complexes 1-4. This process also known as homo- or hetero-oligomerization is due to 
irreversible covalent or reversible electrostatic and hydrophobic protein-protein interactions. 
Oligomerization not only diversifies the different cellular processes without increasing the 
genome size, but also provides a strategy for proteins to build stable complexes that are more 
resistant towards denaturation and degradation 5. Defects in oligomerization have an impact on 
the function of proteins and can lead to the development of diseases. For example, the enzyme 
phenylalanine hydroxylase forms a tetrameric complex. Some mutations within the protein 
complex can weaken the tetramer formation and lead to the disease phenylketonuria 6.  
 
The human MxA protein is an interferon (IFN)-induced antiviral effector protein exerting a 
broad antiviral activity against various RNA as well as DNA viruses 7. It belongs to the 
superfamily of dynamin-like large GTPases and has the capacity to form large oligomeric 
structures in vitro 8. Oligomerization has been suggested to protect MxA from rapid 
degradation 9,10. Despite intense efforts by many research groups, the molecular mechanism of 
action remains largely elusive and the role of the oligomerization state of MxA for its antiviral 
function is under debate 9,11,12. In this regard, Gao and coworkers proposed a model where MxA 
exerts its antiviral activity by interacting with viral nucleoproteins in form of large ring-like 
oligomeric structures 11. However, more recently, we demonstrated that MxA dimers exhibit 
antiviral activity and interact with the nucleoprotein of influenza A virus 12. Based on the crystal 
structure of MxA, Gao and coworkers identified several amino acid residues in the interface 
regions that are critical for its oligomerization in vitro and its antiviral function 11,13. Therefore, 
in order to elucidate which oligomeric state of MxA exerts antiviral activity, we sought to 
establish a simple protocol to rapidly determine the oligmeric state of MxA interface mutants 
expressed in human cells as well as endogenous MxA expressed after IFN stimulation. 
 
Although there are many techniques that are commonly used to investigate the interaction 
between proteins such as the split-Green Fluorescent Protein (split-GFP) complementation 
assay 14, surface plasmon resonance 15 and Förster resonance energy transfer (FRET) 16, they do 
not provide information of the exact stoichiometry of an oligomeric protein complex. For 
investigation of this particular aspect, techniques such as multi-angle light scattering (MALS) 17 
and analytical ultracentrifugation 18 are very useful. Usually, the proteins analyzed using these 
methods are purified proteins. Oligomerization processes may also depend on other cellular 
factors. If these factors are unknown, the analysis is more difficult. Additionally, some proteins 
are difficult to express in E. coli and to purify. Therefore, these methods are not the optimal 
choice to analyze protein oligomerization in the cellular environment. In addition, these 
techniques require expensive instruments which are not readily available. 
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Non-denaturing polyacrylamide gel electrophoresis (PAGE), size exclusion chromatography or 
chemical crosslinking followed by conventional Sodium dodecyl sulfate (SDS)-PAGE are useful 
tools for the characterization of the formation of oligomers from cell lysates 2,19,20. These 
methods do not require specialized equipment and can be easily performed in a standard 
laboratory. We initially evaluated various chemical cross-linking protocols that invariantly led to 
non-specific aggregation and precipitation of MxA. Therefore, we next tested non-denaturing 
PAGE protocols. As non-denaturing PAGE excludes the use of SDS, the migration of proteins 
depends on their native charge. Blue-native PAGE uses coomassie brilliant blue G250 to load 
proteins with an overall negative charge, similar to SDS, but does not denature the protein 21. 
Unfortunately, coomassie brilliant blue precipitates in the presence of high salts and divalent 
cations (e.g. Mg2+) that are often included in lysis buffers. Depending on the buffers used, it 
may be difficult to analyze the sample without further optimization of steps that could have an 
effect on the oligomeric protein complex. 
 
Here we present a simple protocol based on a previously published method 22 to determine 
oligomerization of human MxA protein derived from cellular lysates using non-denaturing 
PAGE. 
 
PROTOCOL:  
 
Note: This protocol is based on the previously published non-denaturing PAGE protocol 12. In 
that study, the oligomeric state of the MxA protein was assessed using either Vero cells 
overexpressing MxA or IFN--stimulated A549 cells expressing endogenous MxA. The protocol 
described below can be used to analyze the oligomeric state of any protein in addition to MxA. 
However, further optimization may be required. 
 
1. Preparation of cell lysate for non-denaturing PAGE 
 
Note: To analyze the oligomeric state of the human MxA protein in either Vero or A549 cells, 
1.0 x 106 cells were harvested. Depending on the cell type or the abundance of the protein to 
analyze, the cell number should be adjusted. It is also important to protect the lysis buffer from 
light exposure, as soon as the light-sensitive iodoacetamide is added. 
 
1.1 Seed 0.3 x 106 A549 or Vero cells per well into 6 well-dishes. Keep the cells in 2 ml 
growth medium per well (see Table 1). Incubate cells overnight in a cell culture incubator (37°C, 
5% CO2). 
1.2 Harvest the cells by washing with 1 ml of phosphate buffered saline (PBS) and detach by 
adding 0.5 ml of 0.25% trypsin-ethylenediaminetetraacetic acid (EDTA) 1(x) solution for 
approximately 5 min at room temperature. 
1.3 As soon as the cells detach from the dish, add 0.5 ml growth medium and carefully mix 
by pipetting up and down. 
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1.4 Transfer the cells of each well into a one 2 ml tube and pellet them using a table top 
centrifuge (5000 x g, 4 °C, 5 min). 
1.5 Carefully remove the supernatant by pipetting without disturbing the cell pellet. 
1.6 Wash the cells with 1 ml ice-cold PBS by carefully pipetting the cell suspension up and 
down. 
1.7 Pellet cells in a table top centrifuge (5000 x g, 4 °C, 5 min). 
1.8 Carefully remove the supernatant by pipetting without detaching the cell pellet.  
1.9 Resuspend cells in 200 l ice-cold lysis buffer (see Table 1) by pipetting up and down 
and put on ice.  
1.10 Immediately, protect lysate from light by covering the tubes using tin foil and incubate 
for 30 min on ice. 
Note: After incubation for 30 min on ice, it is no longer essential to protect the lysate from light 
exposure, since the protection of the free thiol groups is irreversible. 
1.11 Remove cell debris by centrifugation in a pre-chilled table top centrifuge (13000 x g, 4 
°C, 20 min).  
1.12 Equilibrate dialysis columns in dialysis buffer (Table 1) in the cold room at 4 °C for 20 
min during the centrifugation step. Use a column with a molecular weight cut off of 10000.  
1.12.1 Attach the columns to a float buoy and put them into a beaker filled with dialysis buffer. 
To ensure gentle stirring, use a magnetic stirrer. Do not touch the membrane. 
Note: Dialysis columns can be purchased or prepared from 1.5 mL tubes according to the 
protocol described by Fiala and coworkers 19. 
1.13 Remove the columns from the dialysis buffer and the float buoy. Transfer the cleared 
lysates into the prepared dialysis column by pipetting without touching the membrane. Attach 
the columns to a float buoy and put them back into the beaker filled with dialysis buffer. 
1.14 Dialyze the lysate in a beaker containing ice-cold dialysis buffer (Table 1) for at least 4 hr 
(or preferably overnight) at 4 °C while carefully stirring using a magnetic stirrer. Use at least 100 
ml dialysis buffer for a 200 µl lysate. 
1.15 Transfer the dialysed sample into a 1.5 ml tube. Remove precipitates by centrifugation 
in a table top centrifuge (13000 × g, 4 °C, 20 min). To prevent the dissociation of the oligomeric 
protein complexes continue with the protocol (section 2) immediately after dialysis. Do not 
freeze the prepared lysates. 
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2. Electrophoresis 
Note: Electrophoresis was performed as described before with some modifications 22. In the 
protocol described below, pre-cast gradient gels were used (4-15% gradient). Alternatively, the 
gels can be prepared in the laboratory. It is very important to exclude any denaturing agent 
such as SDS to prevent the dissociation of the oligomeric protein complexes. Time of 
electrophoresis was optimized for the different oligomeric states of the human MxA protein. 
However, it can vary for other proteins, depending on the size of the oligomeric complex as well 
as the range of separation that is supposed to be achieved to analyze the complex. Therefore, 
the optimal time of electrophoresis should be determined empirically. For optimal resolution of 
the oligomers to be analyzed the current should not exceed 25 mA.  
2.1 Assemble the non-denaturing PAGE gel in the gel chamber. Fill the inner and outer 
chamber with pre-chilled running buffer (Table 1). 
2.2 Pre-run the gel with pre-chilled running buffer at 25 mA per gel for 15 min in the cold 
room at 4 °C. 
2.3 Mix 15 µl of the above prepared lysates with 5 µl of 4 x sample buffer (Table 1). Do not 
boil the sample. 
2.4 Load 15 µl of sample and a native protein standard of choice on the gel. Run the gel at 
25 mA for 4 hr in the cold room at 4 °C. 
Note: For semi-quantitative analyses, a protein quantification protocol (e.g. a Bradford protein 
assay 23) can be performed in order to ensure loading of equal amounts of total protein per 
lane. 
3. Western Blot 
Note: Described below is the protocol of a wet western blot system. Any blotting membrane 
can be used. Activate polyvinylidene fluoride (PVDF) membranes in 100% methanol before 
equilibration in blotting buffer. The Semi-dry western blot technique can be used alternatively, 
but has to be optimized for large oligomeric complexes. 
3.1 Disassemble the gel and carefully transfer it into SDS buffer (Table 1).  
3.2 Incubate for 10 min at room temperature while gently shaking. 
3.3 Prepare 2 sponges, 4 cellulose filter paper sheets and a blotting membrane per gel. Soak 
them in blotting buffer (Table 1). 
3.4 Assemble the sandwich as follows (bottom to top): 1 sponge, 2 cellulose filter paper 
sheets, membrane, gel, 2 cellulose filter paper sheets, 1 sponge. 
3.5 Put the sandwich into the blotting tank. Make sure that the membrane faces the plus 
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pole while the gel faces the minus pole. 
3.6 Fill the blotting tank with pre-chilled blotting buffer. 
3.7 Blot at 90 mA overnight at 4 °C for best protein transfer results. 
3.8 Disassemble the sandwich and visualize the protein standard by incubating the 
membrane in Ponceau S solution for 5 min at room temperature. 
3.9 Destain the membrane by carefully washing off the Ponceau S with deionized water 
until you can clearly see the bands of the protein standard.  
3.10 Mark the bands of the protein standard using a pen.  
Note: Residual Ponceau S can interefere with the immunostaining. To avoid this, the membrane 
can be destained further by incubation in 0.1 M NaOH for 1 min and subsequent washing with 
deionized water. 
3.11 Destain the membrane with 0.1 M NaOH for 1 min and subsequently wash in deionized 
H2O. 
3.11 Block the membrane with Blocking buffer (see Table 1) for at least 1 hr at room 
temperature or overnight at 4°C. 
3.12 Visualize protein(s) of interest by immunostaining using antibodies directed against the 
protein to be analyzed.  
Note: The human MxA protein was visualized using the rabbit polyclonal antibody specific for 
human Mx1 diluted 1:1000 in Blocking buffer (Table 1). The antibody solution was incubated 
overnight at 4°C. Alternatively, the monoclonal anti-MxA antibody (clone 143) can be used 
(data not shown) 24. 
 
REPRESENTATIVE RESULTS:  
Using non-denaturing PAGE, we analyzed the oligomeric state of the human wild type MxA, the 
dimeric interface mutants MxA(R640A) and MxA(L617D) as well as the monomeric interface 
mutant MxA(M527D) from cell lysates 12. Cells were lysed in a buffer containing 1% 
octylphenoxypolyethoxyethanol (NP-40) and iodoacetamide to ensure protein solubilization 
and protection of free thiol groups (see Figure 1). As described before, salt and small 
metabolites were removed by dialysis 19. Protein separation was carried out by non-denaturing 
PAGE. To facilitate efficient western blotting, the gel was incubated in SDS buffer before 
blotting. The MxA proteins were visualized by immunostaining using a rabbit polyclonal 
antibody directed against MxA. The workflow is described in Figure 2. 
 
To compare the oligomeric state of endogenous human MxA protein from IFN- stimulated 
A549 cells, we transfected Vero cells (lacking endogenous MxA) with recombinant wildtype, 
monomeric and dimeric MxA variants. These recombinant wild type, monomeric and dimeric 
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MxA variants formed stable tetramers, monomers and dimers, respectively, when compared to 
an unstained native protein marker (Figure 3A). Therefore, we used these recombinant proteins 
to assess the oligomeric state of endogenous human MxA protein derived from IFN- 
stimulated A549 cells. Figure 3B reveals that the size of MxA in lysates of IFN-–stimulated 
A549 cells corresponds to a tetramer.  
 
Taken together, we describe a method to determine the oligomeric state of the human MxA 
protein from cell lysate. Our non-denaturing PAGE approach can also be used to assess the 
oligomeric state of other oligomeric protein complexes. 
 
Figure Legends: 
Figure 1: Structure and reaction scheme of iodoacetamide. Iodoacetamide irreversibly 
protects the thiol group of free cysteins by forming a thioether bond. This stable modification 
results from the nucleophilic substitution of the iodine with the sulfur atom from the cystein. 
 
Figure 2: Workflow diagram of non-denaturing PAGE. A systematic representation of the non-
denaturing PAGE approach of cell lysates. During cell lysis, detergents solubilize the proteins 
and thiol groups are protected by iodoacetamide to prevent protein aggregation. Dialysis 
removes small metabolites and salts that could interfere with non-denaturing PAGE 19. The 
complex separation is performed under non-denaturing conditions. Detection of the oligomeric 
complexes is achieved by Western blot followed by immunostaining. 
 
Figure 3: Determination of the oligomeric state of the human MxA protein using non-
denaturing PAGE and Western blotting. (A) Recombinant MxA variants ectopically expressed in 
Vero cells. The complexes of wild type MxA (tetramer) interface mutants MxA(R640A), 
MxA(L617D) (dimers) and MxA(M527D) migrate at their expected molecular weights, 
confirming their oligomeric state. (B) A549 cells were stimulated with 1000 IU per ml of IFN- 
to induce MxA expression. The endogenous MxA shows a band that corresponds to the 
tetrameric form. 
 
Table 1: Buffer recipes required for non-denaturing PAGE.  
 
DISCUSSION: 
Here we describe a simple method that allows the rapid determination of the oligomeric state 
of proteins expressed in mammalian cells by non-denaturing PAGE followed by Western blot 
analysis. The major advantage of this approach is that the oligomeric state of a given protein 
can be determined from whole cell lysates without prior protein purification. This may be 
important for proteins that oligomerize or exert their function in association with auxiliary 
factors. In addition, the proteins are still in their native state and if further extracted from the 
gel, the enzymatic activity or other protein functions can be determined and correlated to the 
oligomeric state. 
 
A critical aspect of this protocol is the choice of detergents during sample preparation. This is of 
particular importance for proteins associated with cellular membranes. MxA appears to be 
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primarily associated with membranes of the smooth endoplasmic reticulum 25. For cell lysis the 
non-ionic detergent NP40 was optimal, preventing the precipitation of MxA. After buffer 
exchange and removal of low molecular weight impurities of the lysates by dialysis as described 
previously 19 the presence of 0.1 % 3-[(3-cholamidopropyl)dimethylammonio]-1-
propanesulfonate (CHAPS) was required to prevent precipitation of MxA during gel 
electrophoresis. In addition, CHAPS does not interfere with the enzymatic activity of MxA as 
determined with purified recombinant MxA protein expressed in E. coli 12. It is of great 
importance that the detergent does not denature the proteins or disrupts protein-protein 
interactions during lysis. Non-denaturing detergents such as NP40, Octoxinol 9, digitonin and 
CHAPS are suitable for solubilization. The choice of the detergent and its concentration should 
be determined empirically. The detergent might also influence downstream experiments e.g. 
for certain assays the detergent needs to be removed which is easily achieved with CHAPS by 
dialysis, but not with Octoxinol 9 26. 
 
Since the described method analyzes proteins derived from cell lysates under non-denaturing 
conditions, no prior purification of the proteins is required. This is an advantage since 
purification of recombinant proteins sometimes requires buffer optimizations by the addition 
of high salts and other additives to prevent the protein from aggregation or precipitation. 
However, these additives and the high salt concentrations might have an impact on the 
oligomerization of the protein that might not necessarily resemble its natural state. Especially 
in the case of the human MxA protein, the salt concentration and the presence of nucleotides 
play a crucial role in the formation of higher oligomeric states 27. In cell lysates, proteins are 
more easily stabilized since the cellular stabilization factors are still present. Therefore it is 
possible to analyze protein complexes under more cell physiological conditions (e.g. 
physiological salt concentrations, and pH). This protocol should also be applicable for other 
proteins forming oligomers, for example for the structurally related MxB or dynamin 8. 
 
Another important aspect of the protocol is the protection of free thiol groups to prevent the 
formation of artificial disulfide bridges of cytoplasmic proteins during lysis (Figure 1). Initial 
experiments showed that addition of 1,4-dithiothreitol (DTT) or -mercaptethanol is not 
sufficient to prevent the formation of artificial disulfide bonds during sample preparation. Both 
reducing agents protect the thiol group reversibly from forming disulfide bridges. This 
reversible protection might not be sufficient to protect all thiol groups permanently. In case of 
the MxA protein, this leads to irreversible aggregation of the protein. However, addition of 
iodoacetamide that irreversibly protects the free thiol groups of cysteines greatly reduced 
aggregation of the MxA protein Furthermore, iodoacetamide treatment of lysates prepared 
from MxA expressing mammalian cells had no influence on the GTPase activity of 
immunoprecipitated MxA when compared to MxA from lysates treated with DTT (data not 
shown). 
 
Other crucial considerations for the exact determination of the number of protomers in an 
oligomer are the choice of the polyacrylamide concentration range as well as the protein 
molecular weight reference. The range of the polyacrylamide concentration should be first 
established to allow maximal separation of the bands at the expected molecular masses of 
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oligomers. Non-denaturing PAGE does not contain any SDS. Lacking SDS, the charge, molecular 
mass and the shape of the protein determines its electrophoretic mobility. Therefore, the 
choice of the protein molecular weight marker is crucial. Ideally, a molecular weight reference 
would be a recombinant purified form of the protein of interest with known oligomeric states. 
Since this is not always available, a non-denatured or native protein marker should be used. 
Since MxA has been shown to associate with other cellular proteins such as UAP56 or viral 
nucleoproteins of Thogotovirus, La Crosse virus or influenza virus 12,28-30, we also tested by 
immunostaining using specific antibodies whether UAP56 or influenza A nucleoprotein would 
co-separate with MxA on the non-denaturing PA gels. However we found no evidence for the 
formation of MxA hetero-oligomers. This probably is due to the fact that MxA-UAP56 and MxA-
nucleoprotein interactions are of low affinity 12,24. Moreover, the fraction of MxA protein 
associating with UAP56 or viral nucleoproteins might be very low and hence difficult to detect 
by this method. 
 
Further, it is important to take into consideration the pKa of the protein to be analyzed. In the 
described non-denaturing PAGE protocol, the proteins are separated by electrophoresis at pH 
8.3. Most proteins are negatively charged at this pH. However, basic proteins exhibit a positive 
net charge at pH 8.3 and therefore will run into the opposite direction. As a consequence, it is 
important, for the analysis of basic proteins to adjust the pH of the running buffer to ensure an 
overall negative charge of the protein. 
 
Taken together we present here a protocol for the rapid assessment of the oligomeric state of 
proteins expressed in mammalian cells without the need of its prior purification.  
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